 |
인쇄하기
취소
|
CJ to launch new diagnostic for diabetic foot disorders.
CJ Pharmaceutical Div. announced that a new diagnostic product, "Neurocheck" would be launched into the market around the end of June after completionof its health registration to KFDA.
Neurocheck determines rapidly and conveniently a foot disorder of diabetic patients and its degree of progression, by its color changes within 10 minutes when applying it to the sole of patient's foot. It's ...
Neurocheck determines rapidly and conveniently a foot disorder of diabetic patients and its degree of progression, by its color changes within 10 minutes when applying it to the sole of patient's foot. It's ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.